On air · 1 of 3 networks
Altasciences
- altasciences.com
- Healthcare & Life Sciences
- CA
- 1,914 employees
Altasciences’s ads on LinkedIn, Meta and Google, recorded by adsrunning. Browse the latest here for free. Sign up free to see all 723. Watch Altasciences with Starter to get each new one in your feed.
Watchlist with Starter · $49/mo
| Network | Status | Live ads | Nov 2025LinkedIn activity · 52 weeksOct 2026 | Checked | Next step |
|---|---|---|---|---|---|
| Running | 439 | Checked 28 Oct 2026 | See all 723 ads → | ||
| Meta | Not checked | — | |||
| Recently | 78 | Ads on the Google Ads Transparency Center | Checked 1 Oct 2026 | Collect them with the API → |
Altasciences has 439 live LinkedIn ads. We recorded 78 Google ads on 1 Oct 2026.
Latest ads
- LINKEDIN · IMAGESince 28 Aug 2026
CNS drug development is complex. Getting to proof of concept doesn’t have to be. An integrated approach reduces handoffs, maintains scientific continuity, and helps your CNS program move faster from safety assessment to proof of concept. Explore CNS Expertise, Faster by Design.
- LINKEDIN · IMAGESince 28 Aug 2026
Complex CNS science. A simpler path forward. Reduce handoffs. Maintain scientific continuity. Move from safety assessment to proof of concept faster with an integrated development approach.
- LINKEDIN · IMAGESince 28 Aug 2026
CNS drug development is complex. Getting to proof of concept doesn’t have to be. An integrated approach reduces handoffs, maintains scientific continuity, and helps your CNS program move faster from safety assessment to proof of concept. Explore CNS Expertise, Faster by Design.
- LINKEDIN · IMAGESince 28 Aug 2026
CNS drug development is complex. Your development model doesn’t have to be. Discover how an integrated approach can reduce handoffs, preserve scientific continuity, and help move CNS programs from safety assessment to proof-of-concept faster. Explore CNS Expertise, Faster by Design.
- LINKEDIN · IMAGESince 28 Aug 2026
Your CNS program is complex. Your development path shouldn’t slow it down. A connected development model helps eliminate unnecessary handoffs, maintain continuity, and keep your program moving toward proof of concept. Advance Your CNS Program, Faster by Design.
- LINKEDIN · VIDEOSince 18 Aug 2026
Droplet digital PCR (ddPCR) is revolutionizing gene and cell therapy research by delivering absolute target quantification and superior sensitivity over traditional qPCR, eliminating the need for standard curves. Kaylyn Koenig, Associate Director of Molecular Biology, explores how this technology: • Enhances biodistribution studies • Improves low-abundance target detection • Advances precision in complex therapeutic workflows Watch the full webinar to explore how ddPCR is advancing biodistribution and gene therapy research: https://lnkd.in/d-eHiE6i #Bioanalysis #NonclinicalResearch #GeneTherapy #DrugDevelopment
6 of 723 adsSign up to see every Altasciences ad, filter by format and date, and get alerts on new ones.
See all 723 adsWatch the companies you care about.
Filter every ad by industry, country, format and network, and get alerts when a company you watch starts running new ads.